SCL vs VTR · P/E 22, rev $2.18B vs P/E 149, rev $4.92B
Stepan Company (SCL) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
SCL currently screens at market cap $1.29B and trailing P/E 22.3. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the SCL and VTR stock pages for the full models.
Not investment advice.